Stock ENDO HEALTH SOLUTIONS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Endo Health Solutions Inc Nasdaq

Equities

US29264F2056

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Endo Health Solutions Inc
Mar. 22 Fourth Amended Joint Reorganization Plan Approved for Endo International plc CI
Mar. 20 Health Care Down on Rate Bias -- Health Care Roundup DJ

Business Summary

Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL and EDEX, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The Company’s Generic Pharmaceuticals segment consists of a product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays.

Sales per Business

USD in Million2022Weight2023Weight Delta
Branded Pharmaceuticals
42.7 %
851 36.7 % 859 42.7 % +0.93%
Generic Pharmaceuticals
32.3 %
795 34.3 % 650 32.3 % -18.24%
Sterile Injectables
21.4 %
590 25.4 % 430 21.4 % -27.15%
International Pharmaceuticals
3.6 %
83 3.6 % 73 3.6 % -12.25%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
96.4 %
2,236 96.4 % 1,939 96.4 % -13.29%
International
3.6 %
83 3.6 % 73 3.6 % -12.25%

Managers

Managers TitleAgeSince
Blaise A Coleman CEO
 Chief Executive Officer 50 14-12-31
Mark Bradley DFI
 Director of Finance/CFO 54 06-12-31
Cheryl Stouch CTO
 Chief Tech/Sci/R&D Officer - -
Susan Williamson CMP
 Compliance Officer - 18-03-31
James Tursi CTO
 Chief Tech/Sci/R&D Officer 59 22-01-17
Laure E. Park IRC
 Investor Relations Contact - 18-08-01
Michael Randolph PRN
 Corporate Officer/Principal - -
Michael McGuinness PRN
 Corporate Officer/Principal - 22-05-31
Frank B. Raciti AUD
 Comptroller/Controller/Auditor - -
Tracy Basso HRO
 Human Resources Officer - 19-06-30

Members of the board

Members of the board TitleAgeSince
Michael Hyatt BRD
 Director/Board Member 78 14-01-31
William Patrick Montague BRD
 Director/Board Member 77 14-02-27
Jennifer Chao BRD
 Director/Board Member 54 21-02-16
Shane Cooke BRD
 Director/Board Member 61 14-07-28
Mark Barberio CHM
 Chairman 61 20-02-18
Nancy Hutson BRD
 Director/Board Member 74 14-02-27
Blaise A Coleman CEO
 Chief Executive Officer 50 14-12-31
Mary Christine Smith BRD
 Director/Board Member 59 20-07-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 235,219,612 233,686,398 ( 99.35 %) 0 99.35 %

Shareholders

NameEquities%Valuation
Blaise A Coleman
0.1794 %
422,066 0.1794 % 169 $
Michael Hyatt
0.1512 %
355,560 0.1512 % 142 $
Matthew Joseph Maletta
0.1493 %
351,085 0.1493 % 140 $
Independence Investments LLC
0.1442 %
339,230 0.1442 % 136 $
Perkins Investment Management LLC
0.1169 %
275,000 0.1169 % 110 $
Chou America Management, Inc.
0.0912 %
214,577 0.0912 % 86 $
Credit Suisse Asset Management LLC
0.0756 %
177,738 0.0756 % 71 $
Eurizon Capital SGR SpA
0.0684 %
160,976 0.0684 % 64 $
Ampega Investment GmbH
0.0510 %
120,000 0.0510 % 48 $
Nancy Hutson
0.0466 %
109,625 0.0466 % 44 $

Company contact information

Endo International Plc

Minerva House Simmonscourt Road

4, Dublin

+353 1 268 2000

http://www.endo.com
address Endo Health Solutions Inc

Group companies

NameCategory and Sector
Par Active Technologies Pvt Ltd.
Logo Par Active Technologies Pvt Ltd.

Par Active Technologies Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Par Active Technologies Pvt Ltd. manufactures pharmaceutical preparations. The company is headquartered in Kancheepuram, India.

Pharmaceuticals: Major
Par Biosciences Pvt Ltd.
Endo Luxembourg Finance Company I SARL
Finance/Rental/Leasing

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+24.60% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.08% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.63% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.37% 317B
ABBVIE INC. Stock AbbVie Inc.
+7.38% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+3.26% 211B
NOVARTIS AG Stock Novartis AG
+0.78% 203B
PFIZER, INC. Stock Pfizer, Inc.
-9.69% 144B
AMGEN INC. Stock Amgen Inc.
-6.63% 141B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ENDPQ Stock
  4. Stock
  5. Company Endo Health Solutions Inc